You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: October 2, 2023

Patent: 7,173,016

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,173,016
Title:Composition and method for treating graft-versus-host disease
Abstract: Compositions and methods are provided for prevention and clinical treatment of various forms of graft-versus-host disease (GVHD) by using inhibitors of adenosine deaminase (ADA). In particular, various formulations and dosing regimens of ADA inhibitors such as pentostatin are provided for the treatment of all forms of GVHD, especially steroid-refractory acute and chronic GVHD.
Inventor(s): DiMartino; Jorge (San Carlos, CA), Nelson; John Tippett (Danville, CA)
Assignee: Mayne Pharma (USA) Inc. (Paramus, NJ)
Application Number:11/208,046
Patent Claims:see list of patent claims

Details for Patent 7,173,016

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Hoffmann-la Roche Inc. ZENAPAX daclizumab Injection 103749 12/10/1997 ⤷  Try a Trial 2021-10-12
Biogen Inc. ZINBRYTA daclizumab Injection 761029 05/27/2016 ⤷  Try a Trial 2021-10-12
Biogen Inc. ZINBRYTA daclizumab Injection 761029 05/26/2017 ⤷  Try a Trial 2021-10-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.